Adviye Ergul to Matrix Metalloproteinase Inhibitors
This is a "connection" page, showing publications Adviye Ergul has written about Matrix Metalloproteinase Inhibitors.
Connection Strength
0.607
-
Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes. Am J Physiol Heart Circ Physiol. 2013 Mar 15; 304(6):H806-15.
Score: 0.398
-
Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke. Stroke. 2016 Mar; 47(3):843-51.
Score: 0.123
-
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci. 2006 Jul 17; 7:56.
Score: 0.063
-
Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke. 2011 Sep; 42(9):2633-5.
Score: 0.022